Search
for
Sort by
Research 301–330 of 561
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Upadacitinib for the treatment of alopecia areata – A case report
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Alopecia Areata: Current Treatments and New Directions
- Effect of different types of therapeutic trauma on vitiligo lesions
- A review of Janus kinase inhibitor use in scarring alopecia
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- Health‐related quality of life and well‐being in pediatric patients with alopecia areata and their caregivers
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Short Snips: YouTube Shorts Recommendations for Hair Loss and Alopecia
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Case Report: Alopecia areata in an adolescent after COVID-19 infection
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Caffeine Supplementation and Hair: A Systematic Review
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis